MECOM and cancer: Heterogeneity in the mutation frequencies was observed in the different tumor types with higher mutation rates found for PRDM3/MECOM, PRDM8, PRDM9, PRDM15, ZFPM1/FOG1 and ZFPM2/FOG2 in specific cancers.